En este estudio pueden participar personas de entre 18 y 80 años de edad con dermatitis atópica (eccema) durante por lo menos 3 años. Los participantes

Adults aged 18 years or older with a diagnosis of active psoriatic arthritis for at least 6 months, may qualify to participate.  Individuals must have

Individuals aged 18 to 80 years with chronic atopic dermatitis (eczema) that has been present for at least 3 years, may qualify for this study.

Adults from 18 to 70 years of age with mild to moderate atopic dermatitis (AD) may qualify to participate.  Individuals must have a history of

Adults from 18 to 75 years of age with a diagnosis of plaque psoriasis, with or without psoriatic arthritis for at least 26 weeks, may

Adults aged 18 or over with a diagnosis of hidradenitis suppurativa (HS) for at least 1 year, may qualify to participate. Individuals must have HS

Individuals aged 2 years and older with a clinical diagnosis of atopic dermatitis (AD), may qualify to participate. Must have moderate to severe disease, with

Adults aged 18 to 65, inclusive, with a clinical diagnosis of moderate-to-severe alopecia areata (AA), defined as the presence of 50% or more and 95%

Adults aged 18 to 75 years (inclusive) with a diagnosis of plaque psoriasis for 24 weeks or more, may qualify for this study. Qualified participants

Adults at least 18 years old with moderate or severe Glabellar Lines (GL) at maximum frown, may qualify to participate in this research trial. These

Individuals aged 12 or older with a clinical diagnosis of nonsegmental vitiligo with depigmented areas, may qualify to participate. Qualified participants must agree to discontinue

Adults at least 18 years of age with a diagnosis of chronic hand eczema (CHE), defined as hand eczema that has persisted for more than